Sex and diabetes intersect in ways that affect quality of life as much as any other medical concern — and yet the topic is undertreated in clinical practice because patients and clinicians alike find it awkward to raise. The good news is that the medical landscape is more favorable than ever: oral medications for ED are highly effective, female sexual dysfunction has emerging treatments, hypoglycemia risk during sex is manageable with a simple glucose-check routine, and pump/CGM logistics have practical solutions. This guide covers the medical, mechanical, and relational sides of the topic in plain language.
Male Sexual Function and Diabetes
Erectile dysfunction (ED) is the dominant issue. Roughly half of men with type 2 diabetes and about 35% of men with type 1 diabetes report some degree of ED. The prevalence climbs sharply with:
- Age over 50
- Diabetes duration over 10 years
- A1C consistently above 8%
- Hypertension and dyslipidemia (especially low HDL)
- Cardiovascular disease — ED often predates a cardiovascular event by 2 to 5 years
- Autonomic neuropathy
- Tobacco use
- Excess alcohol use
- Low testosterone (more common in men with diabetes)
ED Treatment Options
| Option | How it works | Notes |
|---|---|---|
| Sildenafil (Viagra) | PDE5 inhibitor, on-demand | 30-60 min onset, 4 hr duration; food-affected |
| Tadalafil (Cialis) | PDE5 inhibitor, on-demand or daily | 30 min onset, 24-36 hr duration; food-independent |
| Vardenafil (Levitra) | PDE5 inhibitor | Similar to sildenafil |
| Avanafil (Stendra) | PDE5 inhibitor | 15 min onset, shorter duration |
| Alprostadil (injection or urethral) | Vasodilator | For PDE5 non-responders |
| Vacuum erection device | Mechanical | Non-pharmacologic option |
| Penile implant | Surgical | For refractory ED |
| Testosterone replacement | Hormone | Only if documented low T and clinical syndrome |
Female Sexual Function and Diabetes
Female sexual dysfunction in diabetes is underrecognized but real. Specific findings:
- Reduced lubrication and vaginal dryness — both type 1 and type 2
- Decreased arousal and difficulty reaching orgasm
- Decreased libido — often multifactorial including depression, body image, neuropathy
- Higher prevalence of dyspareunia (painful intercourse)
- Higher rates of yeast infections — particularly when glucose runs above 180 mg/dL
- Higher rates of urinary tract infections
- Pelvic floor changes in postmenopausal women with diabetes
Treatment options include vaginal moisturizers (Replens, Hyalo Gyn), water-based lubricants during intimacy, topical vaginal estrogen for postmenopausal women, addressing recurrent infections promptly with antifungal or antibiotic courses, and counseling for psychological components. Glucose control itself improves yeast and UTI rates substantially.
Hypoglycemia During Sex
For insulin-using or sulfonylurea-using individuals, sex is moderate physical activity. Practical management:
- Check glucose if more than 2 hours have passed since the last reading
- If glucose is below 120 mg/dL, ingest 10 to 15 grams of carbohydrate
- Keep glucose tabs or juice at the bedside
- Tell your partner what hypoglycemia looks like (sweating, shakiness, confusion) and where the glucose is
- If wearing a CGM, set the low alert vibration only (not audio) to avoid awkward interruption
- Bolus correction insulin only after, not before, intimacy
- Be aware of delayed hypoglycemia 2 to 8 hours after, especially if sex was preceded by another exercise
Insulin Pump and CGM Logistics
- Tubed pumps (Tandem t:slim, Medtronic 770G/780G) — can be disconnected for 30 to 60 minutes; reconnect afterward
- Tubeless pumps (Omnipod, Ypsomed Mylife) — typically worn through; placement on abdomen, back of arm, or thigh affects positioning
- Suspend pump alarms or set to silent for the duration if leaving connected
- CGM sensors are generally worn — designed for sweat, movement, and skin contact; overpatch helps
- Discuss device placement with a partner — most partners are fine after one conversation
- Pump on bedside table during sleep is a common pattern
- Disconnected pumps should not be off the body for more than 60 minutes without a basal-equivalent bolus to cover the missed delivery
Partner Communication Framework
A practical 5-minute briefing for a partner covers:
- “I have type 1 (or type 2) diabetes.”
- “The main thing to know is low blood sugar — it can happen during exercise, after sex, or anytime.”
- “Signs are sweating, shakiness, confusion, slurred speech, or me becoming unusually quiet or agitated.”
- “If I have a low, I’ll usually grab glucose tabs from the bedside or kitchen counter.”
- “If I can’t help myself, give me sugar — juice, regular soda, glucose tabs.”
- “If I’m not responding or I’m seizing, use the Baqsimi nasal spray (in the bathroom drawer) and call 911.”
- “You don’t have to manage my diabetes — I do that — but if you see something, ask.”
Female-Specific Topics
- Yeast infections. Glucose above 180 mg/dL fuels yeast overgrowth. Topical antifungals (clotrimazole, miconazole) or oral fluconazole are standard. Recurrent infections (4+ per year) warrant a glucose-control review.
- UTIs. SGLT2 inhibitors (empagliflozin, dapagliflozin, ertugliflozin) raise UTI rates further. Hydration and post-coital voiding reduce risk.
- Vaginal dryness. Lubricant during intimacy plus daily vaginal moisturizer between encounters; topical estrogen for postmenopausal users.
- Birth control. All standard methods are available; combined oral contraceptives may need cardiovascular review in women with multiple diabetes complications.
- Pregnancy planning. Pre-conception A1C target under 6.5%; folic acid supplementation; clinician review.
LGBTQ+ Considerations
- Same glucose, insulin, pump, and CGM principles apply regardless of partner gender
- Trans men on testosterone — testosterone can modestly raise insulin resistance; monitor glucose after initiation
- Trans women on estrogen — estrogen does not significantly affect glucose in most users
- PrEP medications for HIV prevention do not interact with diabetes drugs
- Gender-affirming surgery — diabetes control affects wound healing; A1C optimization pre-op is routine
When to Bring It Up with Your Clinician
Sexual concerns are a routine part of diabetes care — clinicians should be asking, and patients should not hesitate to raise the topic. Reasonable triggers for a conversation:
- New or worsening ED
- Recurrent yeast or urinary infections
- Painful intercourse or vaginal dryness
- Decreased libido or arousal
- Concerns about hypoglycemia affecting intimacy
- Pregnancy planning
- Birth control changes
- Relationship concerns related to diabetes management
Related Reading
For broader relationship topics see our piece on dating with diabetes. For partner emergency preparation see parenting with diabetes. For broader treatment context see our treatment overview and complications and related conditions guide.
The Bottom Line
Sex and diabetes intersect in mechanical, medical, and relational ways, and there are practical answers for each. Erectile dysfunction is common in men with diabetes and usually responds to PDE5 inhibitors with primary care management. Female sexual dysfunction is real, less studied, and treatable through a combination of glucose control, lubrication, topical estrogen where appropriate, and prompt treatment of recurrent infections. Hypoglycemia during or after sex is mitigated by a pre-intimacy glucose check and bedside glucose tabs. Pump and CGM logistics are personal preferences that partners adapt to with one conversation. The single most valuable habit is honest communication with a partner about what diabetes looks like in daily life — including in the bedroom.
